The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study: A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics

Kalie L. Tommerdahl; Carissa Vinovskis; Lu Ping Li; Casey M. Rebholz; Cameron Severn; Emily A. Hu; Elizabeth Selvin; Josef Coresh; Morgan E. Grams; Pottumarthi Prasad; Chirag R. Parikh; Petter Bjornstad

doi:10.1016/j.ekir.2022.04.096

The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study: A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics

Kalie L. Tommerdahl
, Carissa Vinovskis
, Lu Ping Li
, Casey M. Rebholz
, Cameron Severn
, Emily A. Hu
, Elizabeth Selvin
, Josef Coresh
, Morgan E. Grams
, Pottumarthi Prasad
, Chirag R. Parikh
, Petter Bjornstad

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1682-1685
Number of pages	4
Journal	Kidney International Reports
Volume	7
Issue number	7
DOIs	https://doi.org/10.1016/j.ekir.2022.04.096
State	Published - Jul 2022

Keywords

beverages
caffeine
coffee
intraglomerular hemodynamic function
renal energetics

ASJC Scopus subject areas

Nephrology

Access to Document

10.1016/j.ekir.2022.04.096

Cite this

Tommerdahl, K. L., Vinovskis, C., Li, L. P., Rebholz, C. M., Severn, C., Hu, E. A., Selvin, E., Coresh, J., Grams, M. E., Prasad, P., Parikh, C. R., & Bjornstad, P. (2022). The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study: A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics. Kidney International Reports, 7(7), 1682-1685. https://doi.org/10.1016/j.ekir.2022.04.096

The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study: A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics. / Tommerdahl, Kalie L.; Vinovskis, Carissa; Li, Lu Ping et al.
In: Kidney International Reports, Vol. 7, No. 7, 07.2022, p. 1682-1685.

Research output: Contribution to journal › Article › peer-review

Tommerdahl, KL, Vinovskis, C, Li, LP, Rebholz, CM, Severn, C, Hu, EA, Selvin, E, Coresh, J, Grams, ME, Prasad, P, Parikh, CR & Bjornstad, P 2022, 'The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study: A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics', Kidney International Reports, vol. 7, no. 7, pp. 1682-1685. https://doi.org/10.1016/j.ekir.2022.04.096

@article{4fcedfa87bc14fbab293a01202c40607,

title = "The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study: A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics",

keywords = "beverages, caffeine, coffee, intraglomerular hemodynamic function, renal energetics",

author = "Tommerdahl, \{Kalie L.\} and Carissa Vinovskis and Li, \{Lu Ping\} and Rebholz, \{Casey M.\} and Cameron Severn and Hu, \{Emily A.\} and Elizabeth Selvin and Josef Coresh and Grams, \{Morgan E.\} and Pottumarthi Prasad and Parikh, \{Chirag R.\} and Petter Bjornstad",

note = "Funding Information: The authors thank the staff and participants of the CASPER and COFFEE studies for their important contributions. KLT receives salary and research support from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) (K23 HL159292), Children's Hospital Colorado Research Institute Research Scholar Award, University of Colorado Diabetes Research Center (P30 DK116073), Ludeman Family Center for Women's Health Research at the University of Colorado, ISPAD-JDRF Research Fellowship, and the Department of Pediatrics, Section of Endocrinology at the University of Colorado School of Medicine. LPL and PP are supported in part from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R21 DK127302). CMR was supported by grants from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK107782, R03 DK128386) and the NIH/NHLBI (R01 HL153178). ES was supported by the NIH/NHLBI (K24 HL152440). PB receives salary and research support from the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK129211, R21 DK129720, K23 DK116720, UC DK114886, and P30 DK116073), JDRF (2-SRA-2019-845-S-B, 3-SRA-2017-424-M-B), Boettcher Foundation, American Heart Association (20IPA35260142), Ludeman Family Center for Women's Health Research at the University of Colorado, the Department of Pediatrics, Section of Endocrinology and Barbara Davis Center for Diabetes at University of Colorado School of Medicine. CRP is supported by NIH/NHLBI (R01 HL085757) and NIH/National Institute of Diabetes and Digestive and Kidney Diseases (UH3 DK114866, U01 DK106962, R01 DK093770). The funders had no role in the study design; collection, analysis, and interpretation of the data; and writing the report; or the decision to submit the report. The interpretation and reporting of the data are the responsibility of the authors and in no way should be seen as official policy or interpretation of the US government. This study was funded by ClinicalTrials.gov identifier: NCT03618420 (CASPER) and NCT03878277 (COFFEE). KLT analyzed and interpreted the data and wrote the manuscript. CV collected, analyzed, and interpreted the data. LPL assisted with MRI postprocessing and analyses. CMR, CS, EAH, ES, LMS, JC, and MEG analyzed and interpreted the data. PP developed the magnetic resonance imaging protocols, postprocessing, and analyses. CRP designed the study, analyzed and interpreted the data, and contributed to discussion. PB designed the study, collected the data, analyzed and interpreted the data, and contributed to discussion. All coauthors reviewed and edited the manuscript. PB is the guarantor of this work and, as such, has full access to the data sets and takes responsibility for the integrity of the data and the accuracy of the data analysis. Funding Information: The authors thank the staff and participants of the CASPER and COFFEE studies for their important contributions. KLT receives salary and research support from the National Institutes of Health (NIH)/ National Heart, Lung, and Blood Institute (NHLBI) (K23 HL159292), Children{\textquoteright}s Hospital Colorado Research Institute Research Scholar Award, University of Colorado Diabetes Research Center (P30 DK116073), Ludeman Family Center for Women{\textquoteright}s Health Research at the University of Colorado , ISPAD-JDRF Research Fellowship, and the Department of Pediatrics, Section of Endocrinology at the University of Colorado School of Medicine . LPL and PP are supported in part from the NIH/ National Institute of Diabetes and Digestive and Kidney Diseases (R21 DK127302). CMR was supported by grants from the NIH/ National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK107782, R03 DK128386) and the NIH /NHLBI (R01 HL153178). ES was supported by the NIH / NHLBI (K24 HL152440). PB receives salary and research support from the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK129211, R21 DK129720, K23 DK116720, UC DK114886, and P30 DK116073), JDRF (2-SRA-2019-845-S-B, 3-SRA-2017-424-M-B), Boettcher Foundation , American Heart Association (20IPA35260142), Ludeman Family Center for Women{\textquoteright}s Health Research at the University of Colorado , the Department of Pediatrics, Section of Endocrinology and Barbara Davis Center for Diabetes at University of Colorado School of Medicine . CRP is supported by NIH/NHLBI (R01 HL085757) and NIH / National Institute of Diabetes and Digestive and Kidney Diseases (UH3 DK114866, U01 DK106962, R01 DK093770). The funders had no role in the study design; collection, analysis, and interpretation of the data; and writing the report; or the decision to submit the report. The interpretation and reporting of the data are the responsibility of the authors and in no way should be seen as official policy or interpretation of the US government. This study was funded by ClinicalTrials.gov identifier: NCT03618420 (CASPER) and NCT03878277 (COFFEE). ",

year = "2022",

month = jul,

doi = "10.1016/j.ekir.2022.04.096",

language = "English (US)",

volume = "7",

pages = "1682--1685",

journal = "Kidney International Reports",

issn = "2468-0249",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study

T2 - A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics

AU - Tommerdahl, Kalie L.

AU - Vinovskis, Carissa

AU - Li, Lu Ping

AU - Rebholz, Casey M.

AU - Severn, Cameron

AU - Hu, Emily A.

AU - Selvin, Elizabeth

AU - Coresh, Josef

AU - Grams, Morgan E.

AU - Prasad, Pottumarthi

AU - Parikh, Chirag R.

AU - Bjornstad, Petter

N1 - Funding Information: The authors thank the staff and participants of the CASPER and COFFEE studies for their important contributions. KLT receives salary and research support from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) (K23 HL159292), Children's Hospital Colorado Research Institute Research Scholar Award, University of Colorado Diabetes Research Center (P30 DK116073), Ludeman Family Center for Women's Health Research at the University of Colorado, ISPAD-JDRF Research Fellowship, and the Department of Pediatrics, Section of Endocrinology at the University of Colorado School of Medicine. LPL and PP are supported in part from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R21 DK127302). CMR was supported by grants from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK107782, R03 DK128386) and the NIH/NHLBI (R01 HL153178). ES was supported by the NIH/NHLBI (K24 HL152440). PB receives salary and research support from the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK129211, R21 DK129720, K23 DK116720, UC DK114886, and P30 DK116073), JDRF (2-SRA-2019-845-S-B, 3-SRA-2017-424-M-B), Boettcher Foundation, American Heart Association (20IPA35260142), Ludeman Family Center for Women's Health Research at the University of Colorado, the Department of Pediatrics, Section of Endocrinology and Barbara Davis Center for Diabetes at University of Colorado School of Medicine. CRP is supported by NIH/NHLBI (R01 HL085757) and NIH/National Institute of Diabetes and Digestive and Kidney Diseases (UH3 DK114866, U01 DK106962, R01 DK093770). The funders had no role in the study design; collection, analysis, and interpretation of the data; and writing the report; or the decision to submit the report. The interpretation and reporting of the data are the responsibility of the authors and in no way should be seen as official policy or interpretation of the US government. This study was funded by ClinicalTrials.gov identifier: NCT03618420 (CASPER) and NCT03878277 (COFFEE). KLT analyzed and interpreted the data and wrote the manuscript. CV collected, analyzed, and interpreted the data. LPL assisted with MRI postprocessing and analyses. CMR, CS, EAH, ES, LMS, JC, and MEG analyzed and interpreted the data. PP developed the magnetic resonance imaging protocols, postprocessing, and analyses. CRP designed the study, analyzed and interpreted the data, and contributed to discussion. PB designed the study, collected the data, analyzed and interpreted the data, and contributed to discussion. All coauthors reviewed and edited the manuscript. PB is the guarantor of this work and, as such, has full access to the data sets and takes responsibility for the integrity of the data and the accuracy of the data analysis. Funding Information: The authors thank the staff and participants of the CASPER and COFFEE studies for their important contributions. KLT receives salary and research support from the National Institutes of Health (NIH)/ National Heart, Lung, and Blood Institute (NHLBI) (K23 HL159292), Children’s Hospital Colorado Research Institute Research Scholar Award, University of Colorado Diabetes Research Center (P30 DK116073), Ludeman Family Center for Women’s Health Research at the University of Colorado , ISPAD-JDRF Research Fellowship, and the Department of Pediatrics, Section of Endocrinology at the University of Colorado School of Medicine . LPL and PP are supported in part from the NIH/ National Institute of Diabetes and Digestive and Kidney Diseases (R21 DK127302). CMR was supported by grants from the NIH/ National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK107782, R03 DK128386) and the NIH /NHLBI (R01 HL153178). ES was supported by the NIH / NHLBI (K24 HL152440). PB receives salary and research support from the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK129211, R21 DK129720, K23 DK116720, UC DK114886, and P30 DK116073), JDRF (2-SRA-2019-845-S-B, 3-SRA-2017-424-M-B), Boettcher Foundation , American Heart Association (20IPA35260142), Ludeman Family Center for Women’s Health Research at the University of Colorado , the Department of Pediatrics, Section of Endocrinology and Barbara Davis Center for Diabetes at University of Colorado School of Medicine . CRP is supported by NIH/NHLBI (R01 HL085757) and NIH / National Institute of Diabetes and Digestive and Kidney Diseases (UH3 DK114866, U01 DK106962, R01 DK093770). The funders had no role in the study design; collection, analysis, and interpretation of the data; and writing the report; or the decision to submit the report. The interpretation and reporting of the data are the responsibility of the authors and in no way should be seen as official policy or interpretation of the US government. This study was funded by ClinicalTrials.gov identifier: NCT03618420 (CASPER) and NCT03878277 (COFFEE).

PY - 2022/7

Y1 - 2022/7

KW - beverages

KW - caffeine

KW - coffee

KW - intraglomerular hemodynamic function

KW - renal energetics

UR - https://www.scopus.com/pages/publications/85130876491

UR - https://www.scopus.com/pages/publications/85130876491#tab=citedBy

U2 - 10.1016/j.ekir.2022.04.096

DO - 10.1016/j.ekir.2022.04.096

M3 - Article

C2 - 35812290

AN - SCOPUS:85130876491

SN - 2468-0249

VL - 7

SP - 1682

EP - 1685

JO - Kidney International Reports

JF - Kidney International Reports

IS - 7

ER -

The Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (COFFEE) Study: A Mechanistic Pilot and Feasibility Study Evaluating Coffee's Effects on Intrarenal Hemodynamic Function and Renal Energetics

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this